StudyOmega-3Moderate

Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017

Read full paper →
Authors
Makoto Kinoshita, Koutaro Yokote, Hidenori Arai, Mami Iida, Yasushi Ishigaki, Shun Ishibashi, Seiji Umemoto, Genshi Egusa, Hirotoshi Ohmura, Tomonori Okamura, Shinji Kihara, Shinji Koba, Isao Saito, Tetsuo Shoji, Hiroyuki Daida, Kazuhisa Tsukamoto, Juno Deguchi, Seitaro Dohi, Kazushige Dobashi, Hirotoshi Hamaguchi, Masumi Hara, Takafumi Hiro, Sadatoshi Biro, Yoshio Fujioka, Chizuko Maruyama, Yoshihiro Miyamoto, Yoshitaka Murakami, Masayuki Yokode, Hiroshi Yoshida, Hiromi Rakugi, Akihiko Wakatsuki, Shizuya Yamashita
Journal
Journal of Atherosclerosis and Thrombosis
Year
2018
Citations
817

Abstract

In the subsections on dyslipidemia in the assessment of risk factors, absolute risk of ASCVD, lipid management targets as well as drug therapy and diet therapy in improving lifestyle habits, we created CQs and performed an SR based on the MINDS method. For our SR, we essentially chose the literature published before the end of 2015.

Test it on yourself

Run a structured omega-3 experiment

The research gives you a prior. Your own data tells you what actually works for you.

Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017 | Steady Practice | SteadyPractice